The phrase "ability of trial" is not commonly used in written English and may sound awkward.
It could be used in contexts discussing the capacity or capability related to a trial or testing process, but it is not a standard expression.
Example: "The ability of trial to assess the effectiveness of the new drug was crucial for the research."
Alternatives: "capacity for testing" or "capability of assessment".
Poor data quality raises doubt on the ability of trial registration to meet the challenge of achieving research transparency, including the ability to adequately address publication bias and selective reporting, and reducing the amount of wasted research [37] [39].
One factor that influences adherence is the ability of trial participants to attend regular clinic visits at which trial products are dispensed, adherence counseling is administered, and participant safety is monitored.
While there is an overwhelming case for strong science-driven trials, the ability of trials to drive basic science should not be underestimated.
High attrition rates in obesity research limit the ability of trials to effectively evaluate treatments and present a major barrier in weight loss research.
We plan to conduct a frequency analysis using the entire MDP 301 dataset which will be important in terms of considering the implications of post-coital intravaginal cleansing on the ability of trials to measure microbicide effectiveness.
In NO16966, there was no statistically significant difference in resection rate or the OS in patients treated with bevacizumab vs placebo, however, the numbers of patients undergoing resection in this trial was small; thus the ability of this trial to detect a difference in resection rates would be quite limited.
This design reduced the burden of data collection of teachers, but it may also have reduced the ability of the trial to detect differences in the incidence of diarrhoea between each trial arm.
This shift might have blurred the ability of this trial to discern a benefit of folic acid.
Many published trials on the use of FFP have enrolled small numbers of patients, and provided inadequate information on the ability of the trial to detect meaningful differences in outcomes between the two patient groups.
Because prevention trials may be prolonged, close attention to concomitant life changes and co-morbidities, adherence and participant retention in the trial is of primary importance, as is recognition of the potential for "preventive misconception" and "behavioral disinhibition" to affect the ability of the trial to show an effect of the intervention under study.
The ability of the trial team to develop messages in this manner was supported by the fact that the sponsors provided key messages for site staff but devolved the responsibility of developing local messages for participants and community members to the site investigators.
